INIBSA is an international pharmaceutical group and a global leader in the dental market, specializing in the manufacture and distribution of dental anesthetics and pain control solutions. Founded in Barcelona in 1948, the company is one of the world's largest producers of dental anesthetics, exporting to over 60 countries. Company Profile Core Business: Inibsa's primary focus is "Pain Control," where it manufactures high-quality dental anesthetic cartridges, dental needles, and syringes. Global Presence: Products are sold in more than 60 countries, and the company has the capacity to produce over one million anesthetic cartridges per day from its facilities in Lliçà de Vall, Barcelona. Product Range: Beyond pain control, Inibsa also markets products in biosafety, surgery, restoration, whitening, and hygiene in Spain and Portugal. Expertise & History: With over 75 years of experience, Inibsa is known for its commitment to innovation, quality, and developing safe and effective solutions for dental professionals. Ownership: As of late 2024, the company's development is supported by Septodont and Acteon, who acquired controlling stakes in the company. Contract Manufacturing: The group's Laboratorios Inibsa division also offers contract manufacturing services for other pharmaceutical companies, including sterile injectable solutions and hard capsules. Mission and Values Inibsa's mission is to make pain-free dentistry accessible to everyone and to assist dental professionals in their daily practice. Key company values include a commitment to customer satisfaction, integrity, efficiency, teamwork, and corporate social responsibility.